<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39">
 <label>39.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Perrin-Cocon</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Aublin-Gex</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sestito</surname>
    <given-names>SE</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shirey</surname>
    <given-names>KA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Patel</surname>
    <given-names>MC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Andr√©</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Blanco</surname>
    <given-names>JC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Vogel</surname>
    <given-names>SN</given-names>
   </name>, 
   <name name-style="western">
    <surname>Peri</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lotteau</surname>
    <given-names>V</given-names>
   </name>
  </person-group>
  <year>2017</year>
  <article-title>TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection</article-title>. 
  <source>Sci Rep</source>
  <volume>7</volume>:
  <fpage>40791</fpage>. doi:
  <pub-id pub-id-type="doi">10.1038/srep40791</pub-id>.
  <pub-id pub-id-type="pmid">28106157</pub-id>
 </mixed-citation>
</ref>
